Daniel Thomas O. - 08 Jun 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 16:13:48 UTC
Previous filing
30 Jun 2022
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +35,000 $0.000000 35,000 08 Jun 2023 Common Stock 35,000 $1.26 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award made pursuant to Non-Employee Director Compensation Program.
F2 The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.